Embecta (EMBC) Cash from Operations Growth (3y) (2023 - 2026)
Embecta (EMBC) Cash from Operations Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.74 Bn | 121.52 Bn | 1.96 Bn | 16.81% |
| 2 | Becton Dickinson | 44.89 Bn | 44.07 Bn | 2.15 Bn | 53.64% |
| 3 | Alcon | 33.18 Bn | 31.52 Bn | 1.53 Bn | 70.05% |
| 4 | Medline | 32.90 Bn | 30.67 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 25.17% |
| 6 | West Pharmaceutical Services | 23.15 Bn | 22.72 Bn | 329.20 Mn | -9.84% |
| 7 | Solventum | 14.12 Bn | 13.55 Bn | 1.10 Bn | -33.35% |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn | 13.75% |
| 9 | Align Technology | 12.17 Bn | 11.11 Bn | 736.59 Mn | -8.92% |
| 10 | Embecta | 205.77 Mn | 12.37 Mn | 127.80 Mn | 63.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.77% |
| Dec 31, 2025 | -34.21% |
| Sep 30, 2025 | 13.14% |
| Jun 30, 2025 | 35.28% |
| Mar 31, 2025 | -44.16% |
| Dec 31, 2024 | -26.79% |
| Sep 30, 2024 | -32.24% |
| Jun 30, 2024 | -26.33% |
| Mar 31, 2024 | -41.23% |
| Dec 31, 2023 | -28.22% |